Yoichiro Miwa Investment Director
Yoichiro Miwa is an Investment Director, joining MGI in 2005. He has focused on life sciences and sustainability investments. He has or had held positions as a board member or observer in over 10 portfolio companies, including QurAlis, Svante, Sirrus Chemistry (M&A) and BioAmber (IPO). Prior to MGI, he held various roles at large companies & startup in life science & advanced materials fields. He holds a MBA from Hult IBS (formerly ADL School of Management) in Cambridge, MA.